본문 바로가기
카테고리 없음

Adoption Scenario of Anti-snoring Devices and Snoring Surgery Market To Remain Positive Through 2022 – 2031 : Fact.MR

by scooptips 2022. 5. 26.

According to Fact MR’s recent market research, sales of Mandibular Advancement Anti-Snoring Devices (MAD) to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Mandibular Advancement Anti-Snoring Devices (MAD) market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4322

Fact.MR- a market research and competitive intelligence provider- establishes that the anti-snoring devices and snoring surgery industry was valued at around US$ 20 Bn in 2020. A five year compounded annual growth rate of 4% is projected until 2025, while long-term forecast projects the market to expand 2x to reach US$ 40 Bn by 2031. Patients showed high inclination towards uvulopalatopharyngoplasty (UPPP) surgeries, accounting for 41% revenue in 2020.

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Mandibular Advancement Anti-Snoring Devices (MAD) market.

Key Segments Covered

  • Device
    • Mandibular Advancement Anti-Snoring Devices (MAD)
    • Tongue Stabilizing Anti-Snoring Device (TSD)
    • Continuous Positive Airway Pressure (CPAP) Anti-Snoring Devices
    • Others (Nasal and Chin Strips, Straps, Rings, etc.)
  • Surgical Procedure
    • Uvulopalatopharyngoplasty (UPPP) Snoring Surgery
    • Tonsillectomy and Adenoidectomy Snoring Surgery
    • Maxillo-Mandibular and Genloglossus Advancement Surgeries
    • Radiofrequency Ablation (RFA) Snoring Surgery
    • Pillar Procedure with Palatal Implants Snoring Surgery

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4322

Competitive Landscape

The anti-snoring landscape is highly fragmented. Few large firms presently dominate the industry in terms of market share. Mid-size to smaller firms, on the other hand, are expanding their market presence by introducing new ingredients at lower prices, thanks to technical advancements and product innovation.

  • In June 2019, InnAccel launched SAANS, a CPAP solution. It is one of the first infrastructure-free, portable, and neonatal CPAP systems in the world, providing a continuous flow of air to prevent the airway from collapsing. It also removes the tissue vibrations that induce snoring.
  • In July 2020, Fisher & Paykel Healthcare inaugurated its 4th research and manufacturing facility at its Daniell Building in New Zealand. This expansion is expected to aid the company in continuing developing and delivering leading healthcare solutions associated with sleep disorders

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/4322

Key Takeaways of Anti-snoring Devices and Snoring Surgery Market Study

  • The over-the-counter availability of anti-snoring devices give them high sales potential over prescribed devices. Relatively easy FDA approvals of these devices and growing trend of online shopping, will, in turn, amplify the penetration of anti-snoring products on a global level.
  • Uvulopalatopharyngoplasty (UPPP) surgery is projected to remain the surgery of choice during the forecast period (2020-2025), estimated to account for ~41% of the total revenue generated in 2020. However, the recent past has witnessed a rapid increase in the number of outpatient care centers offering treatment for snoring. This, coupled with patients looking for minimally-invasive surgeries, is expected to increase the adoption of Radiofrequency Ablation (RFA) surgery during 2020-2025.
  • Manufacturers are increasingly focusing on developing relatively less-invasive products. In addition, efficiency and portability are projected to remain the focal point of R&D activities undertaken by players in the anti-snoring devices and snoring surgery market.
  • Health insurance companies are now including anti-snoring devices and snoring surgery within their insurance coverage, further increasing their adoption. For instance, Medicare collaborated with ResMed Inc. to reimburse a 3-month trial of a CPAP therapy for patients diagnosed with sleep apnea.

“Growing number of sleep labs to treat acute sleep apnea and other sleep disorders creates an extremely conducive environment for the market. As awareness regarding such labs increases, these are projected to turn out as a crucial sales channel for market players”, opines a subject matter expert at Fact.MR.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com